Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1031

1.

Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature.

Vuk A, Kuzman MR, Baretic M, Osvatic MM.

Psychiatr Danub. 2017 Jun;29(2):121-135. Review.

2.

Antipsychotic Treatment of 22q11.2 Deletion Syndrome-Related Psychoses.

Angelopoulos E, Theleritis C, Economou M, Georgatou K, Papageorgiou CC, Tsaltas E.

Pharmacopsychiatry. 2017 Jul;50(4):162-163. doi: 10.1055/s-0043-109559. Epub 2017 May 16. German.

PMID:
28511206
3.

Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs.

Swathy B, Saradalekshmi KR, Nair IV, Nair C, Banerjee M.

Epigenomics. 2017 Jun;9(6):811-821. doi: 10.2217/epi-2016-0181. Epub 2017 Apr 21.

PMID:
28429622
4.

A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.

Feng M, Sparkman NL, Sui N, Li M.

J Psychopharmacol. 2017 Apr;31(4):474-486. doi: 10.1177/0269881116681471. Epub 2016 Dec 14.

PMID:
28347260
5.

Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.

Barber S, Olotu U, Corsi M, Cipriani A.

Cochrane Database Syst Rev. 2017 Mar 23;3:CD006324. doi: 10.1002/14651858.CD006324.pub3. Review.

PMID:
28333365
6.

Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT<sub>2A</sub> receptor agonism.

Aringhieri S, Kolachalam S, Gerace C, Carli M, Verdesca V, Brunacci MG, Rossi C, Ippolito C, Solini A, Corsini GU, Scarselli M.

Eur Neuropsychopharmacol. 2017 Apr;27(4):383-398. doi: 10.1016/j.euroneuro.2017.02.005. Epub 2017 Mar 7.

PMID:
28283227
7.

Determination of drugs in plasma samples by disposable pipette extraction with C18-BSA phase and liquid chromatography-tandem mass spectrometry.

Pinto MAL, de Souza ID, Queiroz MEC.

J Pharm Biomed Anal. 2017 May 30;139:116-124. doi: 10.1016/j.jpba.2017.02.052. Epub 2017 Mar 1.

PMID:
28279926
8.

Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.

Oliveras I, Sánchez-González A, Sampedro-Viana D, Piludu MA, Río-Alamos C, Giorgi O, Corda MG, Aznar S, González-Maeso J, Gerbolés C, Blázquez G, Cañete T, Tobeña A, Fernández-Teruel A.

Psychopharmacology (Berl). 2017 Mar;234(6):957-975. doi: 10.1007/s00213-017-4534-8. Epub 2017 Feb 2.

PMID:
28154892
9.

Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance.

Andrade C.

J Clin Psychiatry. 2016 Dec;77(12):e1656-e1660. doi: 10.4088/JCP.16f11328. Review.

10.

Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia.

Ifteni P, Szalontay AS, Teodorescu A.

Am J Ther. 2017 Mar/Apr;24(2):e222-e226. doi: 10.1097/MJT.0000000000000533.

PMID:
27984264
11.

Effects of antipsychotics on intestinal motility in zebrafish larvae.

de Alvarenga KAF, Sacramento EK, Rosa DV, Souza BR, de Rezende VB, Romano-Silva MA.

Neurogastroenterol Motil. 2017 May;29(5). doi: 10.1111/nmo.13006. Epub 2016 Dec 16.

PMID:
27981679
12.

Time to Discontinuation of Second-Generation Antipsychotics Versus Haloperidol and Sulpiride in People With Schizophrenia: A Naturalistic, Comparative Study.

Chan HY, Pan YJ, Chen JJ, Chen CH.

J Clin Psychopharmacol. 2017 Feb;37(1):13-20. doi: 10.1097/JCP.0000000000000623.

PMID:
27977467
13.

Sedative effect of Clozapine is a function of 5-HT<sub>2A</sub> and environmental novelty.

Joshi RS, Quadros R, Drumm M, Ain R, Panicker MM.

Eur Neuropsychopharmacol. 2017 Jan;27(1):70-81. doi: 10.1016/j.euroneuro.2016.10.007. Epub 2016 Dec 7.

PMID:
27955831
14.

Haloperidol for long-term aggression in psychosis.

Khushu A, Powney MJ.

Cochrane Database Syst Rev. 2016 Nov 27;11:CD009830. Review.

PMID:
27889922
15.

Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries.

Szkultecka-Dębek M, Miernik K, Stelmachowski J, Jakovljević M, Jukić V, Aadamsoo K, Janno S, Bitter I, Tolna J, Jarema M, Jankovic S, Pecenak J, Vavrusova L, Tavčar R, Walczak J, Talbot D, Augustyńska J.

Psychiatr Danub. 2016 Sep;28(3):234-242.

16.

Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.

Choy KH, Shackleford DM, Malone DT, Mistry SN, Patil RT, Scammells PJ, Langmead CJ, Pantelis C, Sexton PM, Lane JR, Christopoulos A.

J Pharmacol Exp Ther. 2016 Nov;359(2):354-365. Epub 2016 Sep 14.

17.

Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study.

Every-Palmer S, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H, Ellis PM.

EBioMedicine. 2016 Mar;5:125-34.

PMID:
27532076
18.

Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.

Sadowska-Bartosz I, Galiniak S, Bartosz G, Zuberek M, Grzelak A, Dietrich-Muszalska A.

Schizophr Res. 2016 Oct;176(2-3):245-251. doi: 10.1016/j.schres.2016.07.010. Epub 2016 Jul 20.

PMID:
27449251
19.

Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon.

Krzystanek M, Bogus K, Pałasz A, Wiaderkiewicz A, Filipczyk Ł, Rojczyk E, Worthington J, Wiaderkiewicz R.

Pharmacol Rep. 2016 Oct;68(5):990-5. doi: 10.1016/j.pharep.2016.05.009. Epub 2016 Jul 6.

PMID:
27391358
20.

The α2C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol.

Uys M, Shahid M, Sallinen J, Dreyer W, Cockeran M, Harvey BH.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Nov 3;71:108-16. doi: 10.1016/j.pnpbp.2016.07.002. Epub 2016 Jul 2.

PMID:
27381554

Supplemental Content

Loading ...
Support Center